Osteoarthritis
‘Alternative’ markers of insulin resistance can predict osteoarthritis
Surrogate measures of insulin resistance, based on the triglyceride-glucose index, can be used to predict the development of osteoarthritis, according to data published in Scientific Reports.
Publicly funded exercise program could reduce joint replacement surgeries, save money
A publicly funded exercise and education program for all patients awaiting joint replacements could reduce surgeries, alleviate wait times and result in net savings, according to data published in Arthritis Care & Research.
Dual mobility components for THA may be justified in high-risk patients
KOLOA, Hawaii — Dual mobility components in total hip arthroplasty are a proven concept that decrease dislocation rates in patients at high risk for instability, according to a presenter here.
Acetaminophen increases risk for hypertension, GI bleeding in patients 65 years and older
Patients aged 65 years and older who use acetaminophen demonstrate greater risks for serious complications, including hypertension, chronic kidney disease and gastrointestinal bleeding, noted a study published in Arthritis Care & Research.
Illness perception, coping styles impact hand osteoarthritis pain over time
Patients’ perception of their illness and coping styles may play a role in whether hand osteoarthritis pain improves or deteriorates over the long term, according to data published in Arthritis Care & Research.
Pain relief may not lead to increased physical activity after knee replacement
WASHINGTON — Pain in patients scheduled for total knee arthroplasty demonstrates no relation to physical activity, suggesting pain relief alone may not improve activity after the procedure, according to a speaker at ACR Convergence 2024.
Low-dose dexamethasone may provide pain relief, improve mobility after TKA
Published results showed a single preoperative IV dose of 8 mg of dexamethasone may improve patient outcomes for pain, vomiting, inflammation and mobility after total knee arthroplasty compared with placebo.
Novel neurotrophin-3 inhibitor offers ‘real hope’ for patients with osteoarthritis pain
WASHINGTON — Patients treated with a novel neurotrophin-3 inhibitor demonstrated significant reductions in osteoarthritis knee pain across all dosing levels, according to data presented at ACR Convergence 2024.
Lorecivivint may be the ‘first disease-modifying treatment’ for knee osteoarthritis
WASHINGTON — Lorecivivint is superior to placebo for improving pain, function and structure at 12 months and beyond in patients with knee osteoarthritis, according to data presented at ACR Convergence 2024.
Weight loss with semaglutide reduces pain, improves function in knee osteoarthritis
Weight loss from weekly semaglutide injections accompanied significant reductions in pain related to knee osteoarthritis, according to data published in The New England Journal of Medicine.